<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>lambda-MYC-induced mouse Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) harboring the shuttle vector pUR288, which includes a lacZ reporter gene to study mutagenesis, was employed to assess genomic instability associated with MYC deregulation </plain></SENT>
<SENT sid="1" pm="."><plain>The frequency of lacZ mutations in <z:hpo ids='HP_0002665'>lymphomas</z:hpo> was elevated only 1.75-fold above that in <z:mpath ids='MPATH_458'>normal</z:mpath> tissue, indicating that mouse <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> does not exhibit a phenotype of hypermutability </plain></SENT>
<SENT sid="2" pm="."><plain>However, the nature of lacZ mutations was strikingly different in <z:mpath ids='MPATH_458'>normal</z:mpath> tissues and <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>While point mutations comprised approximately 75% of the mutations found in <z:mpath ids='MPATH_458'>normal</z:mpath> tissues, apparent translocations, deletions and inversions constituted the majority of mutations ( approximately 65%) in <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Genomic instability in mouse <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> thus seems characterized by a preponderance of illegitimate genetic rearrangements in the context of near-background mutant frequencies </plain></SENT>
<SENT sid="5" pm="."><plain>SKY analyses of cell lines from primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> revealed substantial changes in chromosomal structure, confirming the lacZ studies </plain></SENT>
<SENT sid="6" pm="."><plain>Bi-allelic deletions of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor p16(Ink4a) were detected in six out of 16 cell lines, illustrating cellular selection of advantageous mutations </plain></SENT>
<SENT sid="7" pm="."><plain>Together, these approaches indicate that MYC may contribute to <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e> through the dominant mutator effect of inducing <z:mp ids='MP_0008866'>chromosomal instability</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>The results further suggest that a phenotype of hypermutability (elevated mutant frequency) may not always be required for <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> to occur </plain></SENT>
</text></document>